GNI Group Ltd. 3G6.F Stock
GNI Group Ltd. Price Chart
GNI Group Ltd. 3G6.F Financial and Trading Overview
| GNI Group Ltd. stock price | 13.4 EUR |
| Previous Close | 7.95 EUR |
| Open | 8.85 EUR |
| Bid | 9.45 EUR x 110000 |
| Ask | 10 EUR x 103900 |
| Day's Range | 8.85 - 9.75 EUR |
| 52 Week Range | 6.55 - 14.2 EUR |
| Volume | 300 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 489.98M EUR |
| Beta (5Y Monthly) | 1.362835 |
| PE Ratio (TTM) | 195 |
| EPS (TTM) | 1.15 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
3G6.F Valuation Measures
| Enterprise Value | -11378097152 EUR |
| Trailing P/E | 195 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.02769659 |
| Price/Book (mrq) | 0.021835186 |
| Enterprise Value/Revenue | -0.643 |
| Enterprise Value/EBITDA | -6.976 |
Trading Information
GNI Group Ltd. Stock Price History
| Beta (5Y Monthly) | 1.362835 |
| 52-Week Change | -9.43% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 14.2 EUR |
| 52 Week Low | 6.55 EUR |
| 50-Day Moving Average | 7.06 EUR |
| 200-Day Moving Average | 8.37 EUR |
3G6.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 47.49M |
| Float | 41.96M |
| Short Ratio | N/A |
| % Held by Insiders | 5.56% |
| % Held by Institutions | 6.13% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 3:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0.19% |
| Operating Margin (ttm) | 6.15% |
| Gross Margin | 84.74% |
| EBITDA Margin | 9.21% |
Management Effectiveness
| Return on Assets (ttm) | 2.04% |
| Return on Equity (ttm) | -6.36% |
Income Statement
| Revenue (ttm) | 17.69B EUR |
| Revenue Per Share (ttm) | 372.6 EUR |
| Quarterly Revenue Growth (yoy) | 6.90% |
| Gross Profit (ttm) | 14.74B EUR |
| EBITDA | 1.63B EUR |
| Net Income Avi to Common (ttm) | 35M EUR |
| Diluted EPS (ttm) | 0.05 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 10.79B EUR |
| Total Cash Per Share (mrq) | 227.31 EUR |
| Total Debt (mrq) | 493M EUR |
| Total Debt/Equity (mrq) | 2.49 EUR |
| Current Ratio (mrq) | 4.741 |
| Book Value Per Share (mrq) | 446.527 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 677M EUR |
| Levered Free Cash Flow (ttm) | -1588625024 EUR |
Profile of GNI Group Ltd.
| Country | Germany |
| State | N/A |
| City | Tokyo |
| Address | Nihonbashi-Honcho YS Building |
| ZIP | 103-0023 |
| Phone | 81 3 6214 3600 |
| Website | https://www.gnipharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 701 |
GNI Group Ltd. engages in the research, development, manufacture, and sale of pharmaceutical drugs and traditional Chinese medicines in Japan and internationally. It provides Etuary for the treatment of idiopathic pulmonary fibrosis. The company is also developing Etuary, which is in Phase III clinical trial for the treatment of connective tissue associated interstitial lung disease; and in clinical trial phase II and pre-phase III clinical trial pilot study for the treatment of radiation pneumonitis, as well as for the treatment of diabetic nephropathy. In addition, it is involved in developing F351, which is in Phase II clinical trial for the treatment of liver fibrosis; and F573 that is in pre-clinical phase for the treatment of acute on chronic liver failure, as well as Tamibarotene for the treatment of acute promyelocytic leukemia. GNI Group Ltd. was incorporated in 2001 and is headquartered in Tokyo, Japan.
Q&A For GNI Group Ltd. Stock
What is a current 3G6.F stock price?
GNI Group Ltd. 3G6.F stock price today per share is 13.4 EUR.
How to purchase GNI Group Ltd. stock?
You can buy 3G6.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for GNI Group Ltd.?
The stock symbol or ticker of GNI Group Ltd. is 3G6.F.
Which industry does the GNI Group Ltd. company belong to?
The GNI Group Ltd. industry is Biotechnology.
How many shares does GNI Group Ltd. have in circulation?
The max supply of GNI Group Ltd. shares is 50.55M.
What is GNI Group Ltd. Price to Earnings Ratio (PE Ratio)?
GNI Group Ltd. PE Ratio is 11.65217400 now.
What was GNI Group Ltd. earnings per share over the trailing 12 months (TTM)?
GNI Group Ltd. EPS is 1.15 EUR over the trailing 12 months.
Which sector does the GNI Group Ltd. company belong to?
The GNI Group Ltd. sector is Healthcare.